1. Home
  2. List
Reference Patent

Reference - List

  • 31 Hits
  • Search Condition : Filter (MeSH = Osteoarthritis / pathology)
Species Resource Title
Human and Animal Cells MH7A(RCB1512) Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression.
Human and Animal Cells RAW 264(RCB0535) , NIH3T3 ROCK/actin/MRTF signaling promotes the fibrogenic phenotype of fibroblast-like synoviocytes derived from the temporomandibular joint.
Human and Animal Cells ATDC5(RCB0565) Tumor Necrosis Factor Receptor Associated Factor 3 Modulates Cartilage Degradation through Suppression of Interleukin 17 Signaling.
Human and Animal Cells ATDC5(RCB0565) Spermidine activates RIP1 deubiquitination to inhibit TNF-α-induced NF-κB/p65 signaling pathway in osteoarthritis.
Human and Animal Cells MC3T3-E1(RCB1126) Effect of glucosamine, a therapeutic agent for osteoarthritis, on osteoblastic cell differentiation.
Human and Animal Cells 10T1/2(RCB0247) The intra-articular injection of RANKL-binding peptides inhibits cartilage degeneration in a murine model of osteoarthritis.
Human and Animal Cells ATDC5(RCB0565) A dual role for NOTCH signaling in joint cartilage maintenance and osteoarthritis.
Human and Animal Cells ATDC5(RCB0565) Xanthan Gum Ameliorates Osteoarthritis and Mitigates Cartilage Degradation via Regulation of the Wnt3a/β-Catenin Signaling Pathway.
Human and Animal Cells 10T1/2(RCB0247) , ATDC5(RCB0565) Runx1 contributes to articular cartilage maintenance by enhancement of cartilage matrix production and suppression of hypertrophic differentiation.
Human and Animal Cells ATDC5(RCB0565) Casticin Attenuates Osteoarthritis-Related Cartilage Degeneration by Inhibiting the ROS-Mediated NF-κB Signaling Pathway in vitro and in vivo.
Human and Animal Cells ATDC5(RCB0565) RETRACTED: Notoginsenoside R1 suppresses miR-301a via NF-κB pathway in lipopolysaccharide-treated ATDC5 cells.
Human and Animal Cells ATDC5(RCB0565) Wnt/β-catenin signaling contributes to articular cartilage homeostasis through lubricin induction in the superficial zone.
Human and Animal Cells ATDC5(RCB0565) Artesunate alleviates interleukin‑1β‑induced inflammatory response and apoptosis by inhibiting the NF‑κB signaling pathway in chondrocyte‑like ATDC5 cells, and delays the progression of osteoarthritis in a mouse model.
Human and Animal Cells ATDC5(RCB0565) METTL3 promotes experimental osteoarthritis development by regulating inflammatory response and apoptosis in chondrocyte.
Human and Animal Cells ATDC5(RCB0565) Long noncoding RNA MALAT1 alleviates lipopolysaccharide-induced inflammatory injury by upregulating microRNA-19b in murine chondrogenic ATDC5 cells.
Human and Animal Cells ATDC5(RCB0565) Bushenhuoxue formula attenuates cartilage degeneration in an osteoarthritic mouse model through TGF-β/MMP13 signaling.
Human and Animal Cells ATDC5(RCB0565) Functional polymorphisms in asporin and CILP together with joint loading predispose to hand osteoarthritis.
Human and Animal Cells ATDC5(RCB0565) Halofuginone attenuates articular cartilage degeneration by inhibition of elevated TGF‑β1 signaling in articular cartilage in a rodent osteoarthritis model.
Human and Animal Cells ATDC5(RCB0565) Krüppel-Like Factor 2 Regulates Degradation of Type II Collagen by Suppressing the Expression of Matrix Metalloproteinase (MMP)-13.
Human and Animal Cells Hep G2(RCB1886) , ATDC5(RCB0565) Molecular hydrogen suppresses activated Wnt/β-catenin signaling.